News Agencies Feed

healthcare

Mar 20

Ministers of Health and Industry agree to activate pharmaceutical industry

Ministers of Health and Industry agree to activate pharmaceutical industry

NNA - Minister of Public Health, Dr. Jamil Jabaq, met on Tuesday with Minister of Industry, Wael Abu Faour, with whom he agreed on the need to boost the pharmaceutical industry in Lebanon.


The pair saw eye-to-eye on the need to bolster bilateral cooperation between the"...

Continue Reading >>

Mar 20

Woman conceives after 13 failed IVFs

Woman conceives after 13 failed IVFs

Longing to be a mother, Joelle Nasr tried in-vitro fertilization (IVF) cycle 13 times, each leaving her heart-broken and shattered with no positive results. However, determined to be a parent, Joel did not lose hope and continued her battle with infertility, only to be blessed with twins"...

Continue Reading >>

Mar 19

Fakih IVF to Host a Symposium to Highlight Latest Advances in Reproductive Medicine

Fakih IVF to Host a Symposium to Highlight Latest Advances in Reproductive Medicine

In keeping with HH Sheikh Mohammed’s vision of making Dubai a center of medical excellence, Fakih IVF will host a high-quality annual Continuing Medical Education (CME) symposium from 22nd to 23rd March at Jumeirah Beach Hotel Dubai.

The"...

Continue Reading >>

Mar 19

SpeeDx Distribution Network Expands to the Middle East

SpeeDx Distribution Network Expands to the Middle East

(AETOS Wire)-- SpeeDx Pty. Ltd. have announced signing new partners Al Zahrawi Medical Supplies LLC for distribution of ResistancePlus® and PlexPCR® tests across UAE, Saudi Arabia, Oman, Bahrain, and Qatar.

“Al"...

Continue Reading >>

Mar 18

Childcare is not just a practical problem

Childcare is not just a practical problem

I had been working in childcare for two years before I became a mom. As a founder of Jaleesa, an online platform to find babysitters and nannies in Lebanon, I have spoken to hundreds of parents—mainly moms—about the challenges of work and childcare. Parents have helped us to"...

Continue Reading >>

Mar 18

Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD

Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD

  • Systemic sclerosis (SSc), also known as scleroderma, is a rare chronic connective tissue disease
  • Pulmonary fibrosis, or fibrosing interstitial lung disease (ILD), is a key driver of mortality in people living with SSc and constitutes a high unmet need1,2
  • Improving the lives of people living with pulmonary fibrosis is a key focus...

    Continue Reading >>

Mar 17

NMC Wins ‘UAE Deal of the Year’

NMC Wins ‘UAE Deal of the Year’

NMC, the largest private healthcare provider in the Middle East, was presented with the ‘UAE Deal of the Year’ award for their five-year USD$400m Sukuk transaction at the Islamic Finance News (IFN) Awards 2019.

Commenting"...

Continue Reading >>

Mar 17

Octapharma Group Reports Strong Results for 2018

Octapharma Group Reports Strong Results for 2018

  • Reporting revenue of €1.8 billion and operating income of €346 million
  • Group sales increased 4.5% compared to 2017 (on a constant currency basis, the growth rate is 6.6%)
  • All our products performed well, but to be highlighted are the year-on-year growth of our immunglobulin product portfolio, as well as Nuwiq® and fibryga®
  • ...

    Continue Reading >>

Mar 12

Dental Monitoring Partners with Vitruvian to Accelerate Global Expansion of Its Innovative AI Solutions

Dental Monitoring Partners with Vitruvian to Accelerate Global Expansion of Its Innovative AI Solutions

(AETOS Wire)-- Dental Monitoring (“DM”), provider of the premier suite of Artificial Intelligence solutions in dentistry and orthodontics, has closed a funding round of €45 million, backed by leading growth investor Vitruvian Partners,"...

Continue Reading >>

Mar 11

Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

(AETOS Wire) -- Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a Marketing Authorization Application to the European Medicines Agency (EMA) for ozanimod for the treatment of adults with relapsing-remitting multiple"...

Continue Reading >>